Published in Lab Business Week, January 1st, 2006
An overview of the potential cardioprotective and safety benefits of using estradiol to reduce restenosis in human coronary arteries and the ETHOS I study design was presented at the 2005 Transcatheter Cardiovascular Therapeutic symposium (TCT) by Alexandre Abizaid, MD, PhD, Cardiovascular Research...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week